Meaningful Use Stage 2

Meaningful Use

Stage 2 Overview & Requirements

 

Empower Systems™ Makes Meaningful Use Compliance Easily Attainable for Doctors, Nurses, IT, and Administrators. Empower Systems™ user-friendliness leads to 100% physician acceptance of our ONC Certified Comprehensive EHR solutions. All of the following 15 Meaningful Use Core Measures can be achieved with the assistance of Threshold Reporting for real-time tracking of your facility’s Meaningful Use Compliance. This is the key to taking full advantage of ARRA/HITECH incentives in 2011 and beyond.

This Complete EHR is 2014 Edition compliant and has been certified by an ONC-ACB in accordance with the applicable certification criteria adopted by the Secretary of Health and Human Services. This certification does not represent an endorsement by the U.S. Department of Health and Human Services.

  • VENDOR NAME: EmpowerSystems™
  • DATE CERTIFIED: 7/18/14
  • PRODUCT NAME & VERSION: EmpowerInpatient+Ambulatory Version 1.1.57
  • ONC-ATCB: ICSA Labs
  • CHPL PRODUCT NUMBER: 140186R00
  • LINK TO ONC WEBSITE: Click Here
  • PRODUCT CLASSIFICATION: Modular EHR
  • PRACTICE TYPE: Inpatient
  • ADDITIONAL SOFTWARE: ConnectEHR

The additional types of costs that an Eligible Provider, Eligible Hospital, or Critical Access Hospital would pay to implement this EHR Module’s capabilities in order to attempt to meet meaningful use objectives and measures include:

  • Interface Development
  • Interface Configuration
  • Integration Fees for Health Information Exchange
  • Third Party Database Products to Support Patient Education
  • Third Party Database Products to Support Other Required Patient Services

Certification was granted following rigorous and thorough testing by ICSA Labs, an Accredited Test Lab (ATL), against the following ONC Approved Test Procedures:

170.314(a) Clinical
170.314(a)(1) Computerized provider order entry
170.314(a)(2) Drug-drug, drug-allergy interaction checks
170.314(a)(3) Demographics
170.314(a)(4) Vital signs, BMI and growth charts
170.314(a)(5) Problem list
170.314(a)(6) Medication list
170.314(a)(7) Medication allergy list
170.314(a)(8) Clinical decision support
170.314(a)(9) Electronic notes
170.314(a)(10) Drug-formulary checks
170.314(a)(11) Smoking status
170.314(a)(12) Image results
170.314(a)(13) Family health history
170.314(a)(14) Patient list creation
170.314(a)(15) Patient-specific education resources
170.314(a)(16) Electronic medication administration record
170.314(a)(17) Advance directives
170.314(b) Care Coordination
170.314(b)(1) Transitions of care – receive, display, and incorporate
170.314(b)(2) Transitions of care – create and transmit
170.314(b)(3) Electronic prescribing
170.314(b)(4) Clinical information reconciliation
170.314(b)(5) Incorporate laboratory tests and values/results
170.314(b)(6) Transmission of electronic lab tests and values/results to ambulatory providers
170.314(d) Privacy and Security
170.314(d)(1) Authentication, access control, and authorization
170.314(d)(2) Auditable events and tamper resistance
170.314(d)(3) Audit reports
170.314(d)(4) Amendments
170.314(d)(5) Automatic log-off
170.314(d)(6) Emergency access
170.314(d)(7) End-user device encryption
170.314(d)(8) Integrity
170.314(e) Patient Engagement
170.314(e)(1) View, download and transmit to 3rd party
170.314(f) Public Health
170.314(f)(1) Immunization information
170.314(f)(2) Transmission to immunization registries
170.314(f)(3) Transmission to public health agencies – syndromic surveillance
170.314(f)(4) Transmission of reportable laboratory results and values/results
170.314(g) Utilization
170.314(g)(2) Automated measure calculation
170.314(g)(3) Safety-enhanced design
170.314(g)(4) Quality management system

Important Dates

 

In order to maximize Meaningful Use incentives and meet all compliance deadlines, we have created this high-level overview document for your reference. As milestones pass and new compliance dates are confirmed, this document will be continually updated and shared with our clients.

September 1, 2014 :: Deadline of Data Collection for Any Funds

The last date to begin collecting data to receive any payments is 10/1/2014. Hospitals attesting according to this timeline will receive only 2 payments, which will be 50% and 25% of what their Calculated Yearly Payment would have been, respectively.

October 1, 2014 :: Beginning of Reimbursement Reductions

Hospitals that have not started collecting data by 10/1/2014 may see a reduction in Medicare reimbursement starting in the Federal Fiscal Year 2016.

Attesting Each Subsequent Year

A hospital must attest Each Subsequent Year to receive that year’s payment.  This data collection period is not 90 days; it is now 365 days for payments 2, 3, and 4, which correspond to the Federal Fiscal Year of October 1 to September 30 (10/1-9/30).

Maximum Payments Possible

There are a maximum of 4 yearly payments possible.  The first is the largest, with subsequent payments reduced by a factor of 25% per year.


Attestation Based on Stages

A hospital will attest using the rule that is current (Stage 1 is the current rule as of the drafting of this document). If by the time of the next attestation, Stage 2 has not been finalized (according to CMS it will likely not be 2014), the hospital again attests using Stage 1 as the rule.